CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- NT 10-K Other NT 10-K
- DEFA14A Proxy Proxy Materials
- DEFR14A Other DEFR14A
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
Page 1 of 3 · 59 filings